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EDITORIALLegitimate  division  of  large  datasets,  salami  slicing
and dual  publication.  Where  does  a  fraud  begin?
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cThe  number  of  submitted  manuscripts  is  increasing  sharply
from  year  to  year  in  almost  all  international  journals.  Among
the  many  reasons  for  the  increased  number  of  manuscripts,
salami  slicing  deserves  special  attention.  Salami  slicing  con-
sists  of  splitting  data  from  the  same  research  into  small
units,  each  of  which  is  submitted  —  and  in  many  cases  pub-
lished  —  separately.  Whereas  a  single  study  previously  led
to  the  submission  of  a  single  —  large  —  article,  the  data  may
now  be  divided  into  several  manuscripts,  which  are  subse-
quently  submitted  to  a  single  journal  or  to  several  journals.
The  prevalence  of  salami  slicing,  although  not  unapprecia-
ble,  is  difﬁcult  to  determine.  Reported  values  have  ranged
from  only  1%  [1]  or  1.8%  [2]  to  more  than  15%  [3].  Salami
slicing  is  driven  by  an  author’s  desire  or  need  to  achieve  a
larger  number  of  publications,  in  order  to  gain  recognition,
move  up  on  the  academic  career  ladder,  attract  research
funds  by  increasing  the  institution’s  visibility  and/or  obtain
ﬁnancial  gain  [4—6].
Dividing  a  research  project  into  several  papers  is  not
always  incorrect  or  should  not  be  criticised,  as  some  topics
are  too  large  for  a  single  publication.  A  study  of  partial
anterior  cruciate  ligament  tears,  for  instance,  needs  to  be
reported  in  several  papers,  if  only  to  clarify  the  objectives
(epidemiology,  laxity,  MRI. .  .). Moreover,  a  journal  may  ask
experts  to  write  about  their  ﬁeld  of  knowledge,  in  which
case  the  experts  use  data  from  their  own  previously  pub-
lished  studies,  which  are  cited  in  the  new  paper.
At  the  other  end  of  the  spectrum,  dual  publication  is  a
completely  different  phenomenon.  In  dual  publication,  the
authors  knowingly  submit  two  manuscripts  reporting  iden-
tical  data  to  two  different  journals,  either  simultaneously
or  successively.  This  behaviour,  designated  dual  publica-
tion  or  self-plagiarism  by  ethics  committees  (International
Committee  of  Medical  Journal  Editors  [ICMJE]  [7];  and  the
Committee  on  Publication  Ethics  [COPE]  [8]),  clearly  con-
stitutes  fraud,  since  the  publication  of  a  manuscript  in  a
journal  implies  copyright  transfer  to  that  particular  jour-
nal.  However,  the  publication  of  the  article  in  a  different
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http://dx.doi.org/10.1016/j.otsr.2013.01.001anguage  can  take  place,  provided  the  original  article  is
ited  and  permission  is  obtained  from  the  journal  that  pub-
ished  it.  The  detection  of  dual  publication  invariably  leads
o  a  serious  sanction,  namely,  the  formal  retraction  of  the
rticle.  A  2012  study  [9]  identiﬁed  742  retracted  publica-
ions  in  the  biomedical  literature  over  the  last  10  years,
ith  an  increased  number  in  recent  years.  Dual  publication
s  clearly  the  most  common  reason  for  retraction.  Retrac-
ion  involves  the  notiﬁcation  of  international  databases  and
ournal  publishers  to  explain  the  decision  and  its  reasons.
anning  decisions  may  be  taken  against  the  authors  by  the
ditorial  board(s)  of  the  journal(s)  in  which  the  articles  were
ublished  or  even  by  the  publishers.  In  addition,  if  appli-
able,  a  notice  may  be  sent  to  the  administration  of  the
niversity  with  which  the  authors  are  afﬁliated.  This  usu-
lly  leads  to  serious  negative  consequences  for  the  author  in
uestion  and  could  even  be  described  as  ‘‘career  suicide’’.
In  real  life,  the  limits  between  the  appropriate  division
f  a  manuscript  into  smaller  pieces  worthy  of  publication
s  separate  papers  and  dual  publication  are  hazy:  no  situa-
ions  are  all  black  or  all  white  [5].  Instead,  a continuum
xists  between  the  appropriate  division  of  the  data  and  dual
ublication,  with  salami  slicing  located  somewhere  in  the
iddle.  Editors  are  increasingly  encountering  these  inter-
ediate  cases  of  self-plagiarism.  Salami  slicing  can  take
lace  in  various  ways,  such  as  the  successive  submission  to
he  same  journal  or  to  different  journals  of  manuscripts  on
he  same  topic  based  on  research  conducted,  but  using  the
ame  patient  cohort.  If  the  original  publication  is  cited  in
he  manuscript,  transparency  is  ensured  and  the  editor  can
hen  determine  whether  the  new  information  supplied  by
he  manuscript  is  worthy  of  publication.
In  contrast,  simultaneously  submitting  two  manuscripts
hat  report  exactly  the  same  study  conducted  on  the  same
ohort  but  in  different  formats  (e.g.  original  article  and
echnical  note),  without  informing  the  journals  of  the  dual
ubmission,  indicates  a  deliberate  attempt  on  the  part
f  the  authors  to  conceal  their  behaviour.  In  such  cases,
served.
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∗Corresponding  author.22  
he  editors  are  unable  to  detect  the  dual  submission  and,
f  both  manuscripts  are  accepted,  they  are  published  at
he  same  time.  A  recent  manuscript  published  simulta-
eously  in  Orthopaedics  and  Traumatology:  Surgery  and
esearch  (OTSR)  and  Knee  Surgery  Sports  Traumatology  and
rthroscopy  (KSSTA)  prompted  this  common  editorial.  Delib-
rate  fraud?  Ethical  mistake?  The  distinction  is  a  matter  of
nterpretation.
In  any  case,  dual  publication  must  be  combated  vigor-
usly.  Sanctions  available  to  editors  include  the  retraction
f  the  article,  a  decision  to  ban  the  authors  temporarily  from
ublishing  their  work  in  the  journals,  a  notice  sent  to  editors
nd  publishers  of  other  journals  and  a  letter  of  censure  sent
o  the  authors.  Each  editorial  board  must  choose  from  these
ools  after  obtaining  advice  from  its  ethical  committee.
As  editors,  we  work  very  hard  to  ensure  that  our  readers
an  trust  the  science  reported  in  the  articles  we  publish.  The
anuscripts  are  selected  through  a  painstaking  process  of
eer  review.  In  addition,  a  code  of  publication  ethics  must  be
ccepted  by  the  entire  orthopaedic  community.  In  the  long
erm,  educational  efforts  must  target  all  those  involved,
ncluding  the  authors,  universities,  editorial  boards  and  pub-
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